Search by Drug Name or NDC

    NDC 43063-0884-30 Liothyronine Sodium 25 ug/1 Details

    Liothyronine Sodium 25 ug/1

    Liothyronine Sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is LIOTHYRONINE SODIUM.

    Product Information

    NDC 43063-0884
    Product ID 43063-884_faa87156-e49b-ab71-e053-6394a90a63a7
    Associated GPIs 28100020100310
    GCN Sequence Number 006658
    GCN Sequence Number Description liothyronine sodium TABLET 25 MCG ORAL
    HIC3 P3A
    HIC3 Description THYROID HORMONES
    GCN 26340
    HICL Sequence Number 002850
    HICL Sequence Number Description LIOTHYRONINE SODIUM
    Brand/Generic Generic
    Proprietary Name Liothyronine Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Liothyronine Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units ug/1
    Substance Name LIOTHYRONINE SODIUM
    Labeler Name PD-Rx Pharmaceuticals, Inc.
    Pharmaceutical Class Triiodothyronine [CS], l-Triiodothyronine [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200295
    Listing Certified Through 2024-12-31

    Package

    NDC 43063-0884-30 (43063088430)

    NDC Package Code 43063-884-30
    Billing NDC 43063088430
    Package 30 TABLET in 1 BOTTLE, PLASTIC (43063-884-30)
    Marketing Start Date 2018-08-16
    NDC Exclude Flag N
    Pricing Information N/A